Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 3/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.36 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.36 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.36 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | CDC7 | O00311 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19909085 | 0.95 | FLT3 (0.39) | CYP19A1CYP11B1CYP11B2FLT3ABCG2 | |
| SCHEMBL19909084 | 0.93 | CYP19A1 (0.38) | CYP19A1CYP11B1CYP11B2FLT3ABCG2 | |
| SCHEMBL19913202 | 0.93 | CYP19A1 (0.38) | CYP19A1CYP11B1CYP11B2FLT3ABCG2 | |
| SCHEMBL20923187 | 0.92 | SQOR (0.39) | CYP19A1CYP11B1CYP11B2FLT3ABCG2 | |
| SCHEMBL19919781 | 0.92 | FLT3 (0.39) | CYP19A1CYP11B1CYP11B2FLT3SQOR | |
| SCHEMBL20923078 | 0.92 | CYP19A1 (0.39) | CYP19A1CYP11B1CYP11B2FLT3ABCG2 | |
| SCHEMBL21757799 | 0.92 | NCOA3 (0.41) | CYP11B1CYP11B2SQORNCOA3HPGD | |
| SCHEMBL19909297 | 0.92 | STS (0.38) | CYP19A1CYP11B1CYP11B2FLT3ABCG2 | |
| SCHEMBL19919616 | 0.90 | CYP1A2 (0.40) | FLT3ABCG2SQORHPGDUSP2 | |
| SCHEMBL19909294 | 0.89 | FLT3 (0.34) | CYP19A1CYP11B1CYP11B2FLT3ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-21 | — | — | US | disclosed |
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2020-05-26 | — | — | US | disclosed |
| US-20180062085-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| EP-3287451-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OPRM1, OR51E2 | CYP19A1 2142/4885CYP11B1 610/4885CYP11B2 402/4885 |
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | OR10J3, CFD, AOX1 | CYP19A1 3879/4885CYP11B1 1400/4885CYP11B2 965/4885 |
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | OR10J3, OPRM1, OR51E2 | CYP19A1 2142/4885CYP11B1 610/4885CYP11B2 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.